glp-1 type 1 diabetes news New guidance on the use of GLP-1-based drugs in people with (T1D), due to be published later this year, will address the safety and optimal use of these medications diaTribe.com Releases A Consensus on

Im subscribing!

doi: 10.1186/s40659-022-00404-3 123 ChanYHChaoTFChenSWLeeHFLiPRYehYHet al

While current research doesnt suggest an increased cancer riskin fact, some early data even hint at protective effects in certain cancers, such as recurrent glioma 21 anyone with a current or past cancer diagnosis should consult a physician before starting therapy

The decrease in antioxidant enzyme activities under As stress could be because ROS or direct interactions with As stop or break down these enzymes 42

Data shows that 64% of large firms report that GLP-1 drug coverage for weight loss has moderately or significantly impacted their prescription drug spending